Lhasa will host a free webinar on Feb 24th w/ Andrew Teasdale PhD and Muzaffar Khan PhD to present within our webinar; Controlling potentially mutagenic impurities - hear from industry experts!
Andrew (@AndyTeasdale) is currently the chair of AstraZeneca’s Impurity Advisory Board and has a wealth of knowledge developed over the last 20 years of working within the pharmaceutical industry. He is a leading AZ expert for a number of key impurity areas, including mutagenic impurities (MIs).
Muzaffar (@Muzaffar) is a Senior General Manager within Regulatory Affairs at Laurus Labs Limited - an Indian pharmaceutical and biotechnology company headquartered in Hyderabad. Muzaffar has significant experience of using Mirabilis for proposing pragmatic control strategies for Potential Mutagenic Impurities (PMIs), whilst improving Laurus Labs’ ICH M7 compliance and meeting regulatory expectations.
Information and registration here: https://www.lhasalimited.org/events/2022-webinar-controlling-potentially-mutagenic-impurities-hear-from-industry-experts/10606
@trust_level_1 don’t miss out!